SLSSELLAS Life Sciences Group, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 21721
Ticker: SLS
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2008-03-12
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: SLS

Detail

Enriched 2026-08-14 20:47

Market cap: $2,376,900,994.93
Shares outstanding (class): 196,632,574
Shares outstanding (weighted): 201,945,709
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 13
Location: NEW YORK, NY
Homepage: https://www.sellaslifesciences.com
Description: SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Market cap and share counts drift.

Funds holding this security

53 funds · 53 positions · $82.88M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$21.02M	0.00%	4,969,618 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$19.84M	0.27%	4,689,810 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$17.68M	0.02%	4,180,531 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$8.04M	0.01%	1,900,227 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$5.93M	0.05%	1,402,237 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$1.84M	0.15%	433,818 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$1.18M	0.02%	279,297 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$1.12M	0.00%	265,196 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$757.7K	0.02%	179,124 NS	FIGI
Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust	—	$552.7K	0.05%	130,665 NS	FIGI
LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$482.6K	0.02%	114,100 NS	FIGI
EQ/Small Company Index Portfolio EQ Advisors Trust	—	$390.7K	0.02%	92,360 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$390.5K	0.00%	92,309 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$371.2K	0.00%	87,758 NS	FIGI
Small Cap Index Fund Northern Funds	—	$326.6K	0.02%	77,210 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERSLS
FIGI_COMPOSITEBBG000VC77H7
FIGI_SHARE_CLASSBBG001T223C9
CIK0001390478
ISINUS81642T2096
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: SIC code 2834 indicates pharmaceutical preparations, so it is classified as a pharmaceutical company.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.